During the past decade, Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Apotheke der Universitätsmedizin der Johannes Gutenberg-Universität Mainz (Germany)" with 1 trials as a collaborator, "Axel Hinke. CCRC Cancer Clinical Research Consulting (Düsseldorf, Germany" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Ultimovacs ASA" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken" are "Head and Neck Squamous Cell Carcinoma" (1 trials), "Large Cell Neuroendocrine Carcinoma of the Lung" (1 trials), "Refractory AML" (1 trials) and "Relapsed Adult AML" (1 trials). Many other conditions were trialed in "Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Pembrolizumab injection" (1 trials), "Sargramostim for Injection" (1 trials), "UV1" (1 trials) and "Venetoclax Oral Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".